The global market for Ursodeoxycholic Acid is estimated to increase from US$ 429.4 million in 2021 to reach US$ 889.5 million by 2028, exhibiting a CAGR of 11.0% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Global key players of Ursodeoxycholic Acid include ICE, Dipharma Francis, Daewoong Chemical, Zhongshan Bailing and Dipharma Francis, etc. The top five players hold a share about 70%. The global ursodeoxycholic acid are mainly produced in Europe and East Asia, they occupied for a share about 70%. The largest market is Asia-Pacific, holds a share about 50%, followed by Europe and North America, with around 31% and 17% market share respectively.
Report Coverage
This latest report provides a deep insight into the global Ursodeoxycholic Acid market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Ursodeoxycholic Acid market, with both quantitative and qualitative data, to help readers understand how the Ursodeoxycholic Acid market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Ursodeoxycholic Acid market and forecasts the market size by Type (Synthetic UDCA and Extraction UDCA,), by Application (Pharmacy and Health Products.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Synthetic UDCA
Extraction UDCA
Segmentation by application
Pharmacy
Health Products
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhongshan Bailing
Dipharma Francis
Grindeks
Suzhou Tianlv
Yun Gang Bio
Chapter Introduction
Chapter 1: Scope of Ursodeoxycholic Acid, Research Methodology, etc.
Chapter 2: Executive Summary, global Ursodeoxycholic Acid market size (sales and revenue) and CAGR, Ursodeoxycholic Acid market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Ursodeoxycholic Acid sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Ursodeoxycholic Acid sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Ursodeoxycholic Acid market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Zhongshan Bailing, Dipharma Francis, Grindeks, Suzhou Tianlv and Yun Gang Bio, etc.
Chapter 14: Research Findings and Conclusion